ZAFGEN, INC. Business Finance Contracts & Agreements
29 Contracts & Agreements
- Exchange Agreements (2 contracts)
- Investor Rights Agreements (3)
- Loan Agreements (1)
- Registration Rights Agreements (3)
- Stock Agreements (11)
- Subscription Agreements (1)
- Underwriting Agreements (5)
- Waiver Agreements (1)
- Warrant Agreements (2)
- Non-Qualified Stock Option Grant Notice and Award Agreement (Filed With SEC on March 14, 2024)
- Underwriting Agreement, dated February 14, 2024, by and among the Company, Leerink Partners LLC, Citigroup Global Markets Inc. and Guggenheim Securities, LLC, as representatives... (Filed With SEC on February 16, 2024)
- Underwriting Agreement (Filed With SEC on September 14, 2022)
- Form of Amended and Restated Registration Rights Agreement, by and among Larimar Therapeutics, Inc. and certain Investors (Filed With SEC on May 21, 2021)
- Form of Registration Rights Agreement, by and among Larimar Therapeutics, Inc. and certain Investors (Filed With SEC on May 21, 2021)
- Securities Purchase Agreement, dated as of May 21, 2021, by and among Larimar Therapeutics, Inc. and the investors listed on the Schedule of Investors attached thereto (Filed With SEC on May 21, 2021)
- Form of Pre-Funded Warrant (Filed With SEC on May 21, 2021)
- Larimar Therapeutics, Inc. Form of Stock Option Grant Notice and Award Agreement (Filed With SEC on September 29, 2020)
- Larimar Therapeutics, Inc. Form of Stock Option Grant Notice and Award Agreement (Filed With SEC on September 29, 2020)
- Registration Rights Agreement, dated as of June 1, 2020 by and among Larimar Therapeutics, Inc. and certain Investors (Filed With SEC on June 2, 2020)
- Securities Purchase Agreement, dated as of May 28, 2020 by and among Larimar Therapeutics, Inc. and the investors listed on the Schedule of Investors attached thereto (Filed With SEC on June 2, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on June 2, 2020)
- First Amendment to Non-Qualified Stock Option Agreement Inducement Award by and between Registrant and Jeffrey S. Hatfield granted on October 9, 2017 (Filed With SEC on March 5, 2020)
- Description of Registrants Securities 10.1# Amended and Restated 2006 Stock Option Plan and forms of award agreements thereunder (incorporated by reference to Exhibit 10.1 of the... (Filed With SEC on March 5, 2020)
- Non-Qualified Stock Option Agreement Inducement Award by and between the Registrant and Priya Singhal, M.D., M.P.H. granted on April 2, 2019 (Filed With SEC on May 9, 2019)
- Non-Qualified Stock Option Agreement Inducement Award by and between Registrant and Brian P. McVeigh granted on May 29, 2018 (Filed With SEC on August 9, 2018)
- Underwriting Agreement, dated as of June 27, 2018, among Zafgen, Inc. and Cowen and Company, LLC and Piper Jaffray & Co., as representatives of the underwriters named therein (Filed With SEC on June 28, 2018)
- Waiver to Financing Condition by and between Registrant and Jeffrey S. Hatfield, effective as of December 29, 2017 (Filed With SEC on March 9, 2018)
- Non-Qualified Stock Option Agreement Inducement Award by and between Registrant and Jeffrey S. Hatfield granted on October 9, 2017 (Filed With SEC on March 9, 2018)
- Non-Qualified Stock Option Agreement Inducement Award by and between Registrant and Jeffrey S. Hatfield granted on October 9, 2017 (Filed With SEC on March 9, 2018)
- Loan and Security Agreement dated December 29, 2017 between Zafgen, Inc., as borrower, and Silicon Valley Bank, as lender (Filed With SEC on January 5, 2018)
- ZAFGEN, INC. [] Shares of Common Stock, par value $0.001 per share Underwriting Agreement (Filed With SEC on January 16, 2015)
- SUBSCRIPTION AGREEMENT (Filed With SEC on January 12, 2015)
- ZAFGEN, INC. 2014EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on June 5, 2014)
- ZAFGEN, INC. [] Shares ofCommon Stock, par value $0.001 per share Underwriting Agreement (Filed With SEC on June 5, 2014)
- ***Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 230.406 EXCLUSIVE... (Filed With SEC on April 18, 2014)
- ***Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 230.406 EXCLUSIVE... (Filed With SEC on April 18, 2014)
- ZAFGEN, INC. AMENDED AND RESTATED 2006 STOCK OPTIONPLAN (Filed With SEC on April 18, 2014)
- THIRD AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT BY AND AMONG ZAFGEN,INC. AND THEINVESTORS NAMED HEREIN November 25, 2013 TABLE OF CONTENTS (Filed With SEC on April 18, 2014)